Position Paper

Osteoporosis International

, Volume 24, Issue 1, pp 23-57

Open Access This content is freely available online to anyone, anywhere at any time.

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  • J. A. KanisAffiliated withWHO Collaborating Centre, UK University of Sheffield Medical SchoolWHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School Email author 
  • , E. V. McCloskeyAffiliated withWHO Collaborating Centre, UK University of Sheffield Medical School
  • , H. JohanssonAffiliated withWHO Collaborating Centre, UK University of Sheffield Medical School
  • , C. CooperAffiliated withMRC Lifecourse Epidemiology Unit, University of Southampton and NIHR Musculoskeletal Biomedical Research Unit, University of Oxford
  • , R. RizzoliAffiliated withUniversity Hospitals and Faculty of Medicine of Geneva
  • , J.-Y. ReginsterAffiliated withDepartment of Public Health, Epidemiology and Health Economics and HEC School of Management, University of Liège
  • , on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF)Affiliated withDepartment of Public Health, Epidemiology and Health Economics and HEC School of Management, University of Liège

Abstract

Summary

Guidance is provided in a European setting on the assessment and treatment of postmenopausal women at risk of fractures due to osteoporosis.

Introduction

The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2008. This manuscript updates these in a European setting.

Methods

Systematic literature reviews.

Results

The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk, general and pharmacological management of osteoporosis, monitoring of treatment, assessment of fracture risk, case finding strategies, investigation of patients and health economics of treatment.

Conclusions

A platform is provided on which specific guidelines can be developed for national use.

Keywords

Bone mineral density Diagnosis of osteoporosis Fracture risk assessment FRAX Health economics Treatment of osteoporosis